Skip to search formSkip to main contentSkip to account menu

NHL-BFM-90 Regimen

Known as: BFM-90 Regimen 
A regimen used for the treatment of localized aggressive forms of childhood B-cell non-Hodgkin's lymphoma, including lymphoblastic lymphoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Introduction.Diffuse large B-cell lymphoma of postgerminal origin (ABC-DLBCL) and follicular lymphoma grade 3B (FL3B) are… 
2019
2019
Objective: To evaluate the efficacy and safety of rituximab combined with the modified NHL-BFM-90 protocol in childhood and… 
Review
2018
Review
2018
Diffuse large B-cell lymphoma is categorized by gene expression profiling into germinal center (GCB) and activated B-cell (ABC… 
2017
2017
  • W. ZhengH. Ren Jun Zhu
  • Chinese journal of cancer research = Chung-kuo…
  • 2017
  • Corpus ID: 15180374
Objective Although L-asparaginase (L-ASP) is a standard treatment for lymphoblastic lymphoma (LBL), hypersensitivity reactions by… 
2009
2009
AIM To evaluate efficacy of intensive modified program NHL-BFM-90 (mNHL-BFM-90) in adult poor-prognosis patients with diffuse… 
2007
2007
OBJECTIVE This study was designed to evaluate the efficacy and toxicity of modified BFM-90 regimen originated from Germany…